Alex Lindsay

Alex Lindsay is an associate in Goodwin’s Private Equity group. He provides strategic counsel to private equity sponsors and corporates on a wide range of transactions, including leveraged buyouts, mergers, acquisitions and divestures, joint ventures, growth equity, structured capital investments, equity and debt restructurings and management equity plans, as well as related advisory work.

Alex has a wealth of experience across a broad range of industry sectors, including financial services, ICT, life sciences, insurance, real estate, hospitality and retail.

Private Equity and Special Situations

• Bregal Sagemount on its growth equity investment in Enhesa, a leading global provider of regulatory and sustainability intelligence
• Creat-backed Tiancheng International
  • on the disposal of its majority stake in Bio Products Laboratory, a specialist in the development of rare disease products using fractionated blood plasma, to Permira
  • on its proposed €1.1 billion sale to Grifols of its indirect majority stake in Biotest, a specialist in innovative hematology and clinical immunology solutions
• York Capital Management and its portfolio company Cennox on their acquisition of iTech, a leading Irish transport provider providing specialised services associated with moving and locating high technology equipment
• TA Associates on its combination of Compusoft with Genstar-backed 2020 Technologies to create a global provider of planning and manufacturing solutions for residential and commercial spaces
• Shareholders of Receipt Bank / Dext on its majority sale to Hg Capital
• Queens Park Equity
  • and DCSL in connection with the acquisition and integration of Guidesmiths Limited to form DCSL Guidesmiths
  • on the leveraged acquisition of Sagacity Group, a London-based IT consultancy company
• All Seas Capital on its structured capital investment in Hakim, the UK’s leading independent chain of opticians*
• Five Arrows Principal Investments in its sale of and co-investment in Datix, a patient safety and risk management software company*
• GHO Capital on the acquisition of Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma*
• GIC on its investment in Convex Group Limited, the specialty insurer and reinsurer focused on complex risks, which launched with US$1.7 billion of committed capital in April of 2019. The investment was part of a GIC and Onex Corporation led consortium of existing and new co-investors committing to invest an additional US$1 billion in Convex*
• TowerBrook Capital Partners on the acquisition of the Azzurri Group, the owner of the ASK Italian, Zizzi and Coco di Mama brands, along with the Pod Food Limited fast food delivery service via a pre-pack administration sale, following a competitive bid process*

Corporate M&A

• F. Hoffmann-La Roche on its acquisition of a UK-based pre-clinical immuno-oncology company which has developed an antibody with a novel mode of action aimed at depleting regulatory T-cells*
• Maitland Financial Services on the sale of its hedge-fund administration business to Mitsubishi UFJ Financial Group*
• Travelex on its financial and operational restructuring* 

*Denotes experience prior to joining Goodwin.